Clinical Guides
Guillain-Barré Syndrome
A clinically focused guide to recognising Guillain-Barré syndrome, protecting ventilation and swallowing, using cerebrospinal-fluid and nerve-conduction studies appropriately, and delivering time-critical immunotherapy and rehabilitation across Indian care settings.
MedNext Academy | 14 min read
Guillain-Barré Syndrome
A clinically focused guide to recognising Guillain-Barré syndrome, protecting ventilation and swallowing, using cerebrospinal-fluid and nerve-conduction studies appropriately, and delivering time-critical immunotherapy and rehabilitation across Indian care settings.
Summary
Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy and a neurological emergency. The usual pattern is rapidly evolving, relatively symmetrical limb weakness with reduced or absent reflexes, often after a respiratory or gastrointestinal infection. Distal paraesthesia, radicular or back pain, facial weakness, bulbar dysfunction, autonomic instability and respiratory muscle weakness may accompany the motor deficit. Variants include acute inflammatory demyelinating polyradiculoneuropathy, acute motor axonal neuropathy, acute motor-sensory axonal neuropathy and Miller Fisher syndrome. The pattern can ascend, but clinicians should not wait for textbook progression before acting.
Every suspected case needs hospital assessment because respiratory failure, aspiration, arrhythmia and labile blood pressure may develop despite a deceptively normal oxygen saturation. Serial bedside respiratory measurements, cough and swallowing assessment, limb-power documentation, cardiac rhythm and haemodynamic surveillance are core care. Cerebrospinal fluid and nerve-conduction studies support classification and exclude alternatives; neither should delay treatment when clinical probability and severity justify it. Albuminocytological dissociation may be absent early, and initial electrodiagnostic studies may be non-diagnostic.
Intravenous immunoglobulin and plasma exchange are effective disease-modifying options when given to appropriate patients early; they are not routinely combined, and corticosteroids do not improve GBS. Prevention of venous thromboembolism, pressure injury, infection and contracture, together with analgesia, nutrition, communication and multidisciplinary rehabilitation, materially affects outcome. Recovery often takes months, and fatigue, pain or weakness may persist. Diagnosis and treatment must remain specialist-led because mimics such as spinal cord compression, myasthenic crisis, botulism, hypokalaemia and acute flaccid myelitis require different actions.
How Common Is It?
GBS is uncommon but occurs worldwide and at every age. The 2023 European Academy of Neurology and Peripheral Nerve Society guideline describes an incidence in the order of one to two people per 100,000 person-years, with incidence increasing with age and a modest male predominance. These figures are pooled international estimates rather than a contemporary Indian national rate. Referral studies, differing case definitions, incomplete electrodiagnostic access and surveillance during infectious outbreaks can all change reported frequency. A numerical estimate should therefore never reduce vigilance in an individual with a compatible rapid weakness syndrome.
Approximately two thirds of patients report a preceding infection, classically diarrhoea or an upper-respiratory illness. Campylobacter jejuni is a well-established trigger, and cytomegalovirus, Epstein-Barr virus, influenza and other infections have associations. A temporal association does not prove which organism caused an individual case, and pathogen testing is usually unnecessary for the neurological diagnosis. Vaccination-associated GBS is rare; infection generally presents a much larger GBS risk than vaccination, so unqualified anti-vaccine conclusions are unsafe.
Indian case mix includes demyelinating and axonal electrophysiological subtypes, but proportions differ by region, season, methods and referral level. Patients reaching tertiary intensive care are not representative of every case. The useful population message is that a rare syndrome can create a high-acuity bed, ventilation and rehabilitation burden. Services should plan rapid transfer and monitoring rather than use rarity to justify outpatient observation. Local audit should capture time to admission, respiratory measurement, immunotherapy, ventilation, complications and functional outcome using a defined diagnostic framework.
Risk Factors
A recent infectious illness is the most frequent clinical association. Ask specifically about diarrhoea, fever, cough, sore throat or another systemic illness during the preceding six weeks, while recording exact timing and recovery. Campylobacter-associated molecular mimicry is linked particularly to some axonal phenotypes, but the preceding illness may have resolved before weakness begins. Recent surgery can precede GBS, and pregnancy or the postpartum period changes practical assessment and thrombosis risk, although neither establishes causation. A previous GBS episode is uncommon but relevant because recurrence prompts careful confirmation and consideration of acute-onset chronic inflammatory demyelinating polyradiculoneuropathy.
Medication and exposure history matters mainly because it reveals mimics. Ask about chemotherapy, immune checkpoint inhibitors, nitrofurantoin, metronidazole, isoniazid, organophosphate or heavy-metal exposure and recreational nitrous oxide. Document vaccination dates neutrally. The EAN/PNS guideline advises that, in most people whose GBS occurred more than six weeks after a vaccination, routine future vaccination need not automatically be withheld. A prior episode within six weeks of a particular vaccine requires individual specialist risk-benefit review rather than a blanket rule.
Diabetes, renal dysfunction, frailty, obesity, chronic lung disease and pre-existing neuropathy may complicate examination, intravenous immunoglobulin selection, thrombosis risk or ventilatory reserve. They are not diagnostic risk factors. Children may show pain, refusal to walk or irritability before weakness is recognised. Older adults can deteriorate rapidly and have less physiological reserve. In India, delayed travel, self-medication, inability to fund IVIG and limited ICU availability amplify harm after onset; these are access risks, not biological causes. No risk factor safely excludes spinal, metabolic, toxic, infectious or neuromuscular-junction alternatives.
Diagnosis
History
Establish the first neurological symptom, day-by-day progression and current peak deficit. Ask about symmetrical leg or arm weakness, difficulty rising, walking, gripping, lifting the head, closing the eyes, speaking, chewing or swallowing. Record paraesthesia, severe radicular or back pain, diplopia, ataxia, urinary retention, palpitations, sweating and presyncope. Ask about breathlessness when supine, weak cough, broken speech, choking and inability to count in one breath, but do not rely on dyspnoea because respiratory weakness may be silent. A sensory level, early sphincter syndrome, fever at neurological onset, marked asymmetry or progression beyond eight weeks argues for alternatives.
Examination
Document Medical Research Council power in proximal and distal muscle groups, tendon reflexes, plantar responses, sensation, coordination and gait if safe. Examine eye movements, facial closure, palate, tongue, neck flexion, cough strength and secretion handling. Measure respiratory rate, single-breath count, forced vital capacity and inspiratory pressure serially using the same technique where available. Pulse oximetry can remain normal until late and does not measure ventilation. Monitor ECG, heart rate and blood pressure for dysautonomia; avoid provoking profound bradycardia during suction or procedures.
Investigations
Cerebrospinal fluid commonly shows raised protein with few cells, but protein can be normal in the first week. A substantial pleocytosis should prompt infection, inflammation or malignancy review. Nerve-conduction studies and electromyography support diagnosis, subtype and mimic exclusion; repeat testing can be necessary when early results are normal or equivocal. MRI is selected to exclude cord, cauda-equina or brainstem disease, not to prove routine GBS. Test electrolytes, glucose, renal and liver function, blood count and other alternatives. Anti-ganglioside antibodies are most useful in selected variants, such as anti-GQ1b in Miller Fisher syndrome, and a negative result does not exclude GBS.
Differential Diagnosis
Spinal cord compression, transverse myelitis and spinal infarction can produce acute weakness but are favoured by a sensory level, brisk reflexes after spinal shock resolves, extensor plantar responses, sphincter disturbance or focal spinal pain. Cauda-equina compression causes saddle sensory change and bladder or bowel dysfunction and needs emergency imaging. Brainstem stroke can cause bulbar and limb findings with an abrupt onset or central signs. Acute flaccid myelitis often has pronounced asymmetry and spinal grey-matter abnormalities. Poliomyelitis remains a surveillance diagnosis in acute flaccid paralysis and must follow public-health pathways where relevant.
Myasthenic crisis produces fatigable ocular, bulbar and respiratory weakness without sensory symptoms and usually preserves reflexes. Botulism often descends from pupils and bulbar muscles and may follow contaminated food or a wound. Tick paralysis, diphtheritic neuropathy, porphyria, neurotoxic snakebite and organophosphate poisoning require exposure-specific treatment. Hypokalaemia, hypophosphataemia and severe metabolic disturbance are identified urgently because correction can be rapidly effective. Critical-illness neuropathy develops in the context of severe systemic illness rather than as a typical antecedent syndrome.
Chronic inflammatory demyelinating polyradiculoneuropathy generally progresses beyond eight weeks or relapses repeatedly. A treatment-related fluctuation can occur in GBS, but multiple deteriorations or late worsening should trigger reassessment for acute-onset CIDP. Vasculitic neuropathy is often painful and asymmetric; diabetic lumbosacral radiculoplexus neuropathy is focal or asymmetric. Functional neurological disorder can coexist with organic disease and should be diagnosed using positive clinical signs, never because tests are early or access is limited. Preserved reflexes do not absolutely exclude GBS variants, so diagnostic synthesis and serial examination are essential.
Management
Admit suspected GBS to a unit able to repeat neurological, bulbar, respiratory and autonomic assessment. Escalate early to ICU when forced vital capacity is falling, cough is weak, secretions accumulate, swallowing fails, bulbar weakness progresses, oxygen or carbon-dioxide abnormalities appear, arrhythmia or blood-pressure swings occur, or weakness evolves rapidly. Planned intubation is safer than a crash airway; clinical trajectory, gas exchange, airway protection and respiratory measurements must be integrated rather than waiting for one threshold. Avoid excessive sedation and prepare for haemodynamic instability during airway procedures.
The EAN/PNS guideline recommends IVIG at a total 2 g/kg over two to five days for patients unable to walk unaided when treatment starts within two weeks of weakness onset. Plasma exchange, typically four to five exchanges over one to two weeks, is recommended when started within four weeks in similarly affected patients. The same therapies may be considered in ambulant patients with rapid progression or bulbar, respiratory or autonomic risk. Choice depends on contraindications, timing, venous access, haemodynamic stability, local expertise, product supply and cost. Routine sequential plasma exchange immediately after IVIG is not beneficial, and a second IVIG course solely for a poor prognostic score is not recommended.
Corticosteroids are not effective treatment for GBS. Supportive care includes thromboprophylaxis when appropriate, pressure-area and corneal care, infection prevention, bowel and bladder management, adequate calories, pain treatment and cautious physiotherapy without exhausting denervated muscle. Communicate with intubated patients and address fear, sleep and delirium. Begin rehabilitation early, set realistic milestones and reassess persistent deterioration. Treatment does not guarantee rapid recovery or prevent every complication.
Prescribing Information
IVIG dosing is calculated from body weight under a neurologist-led local protocol; the commonly recommended total course is 2 g/kg divided across two to five days. Before infusion, review renal function, hydration, thrombosis history, hyperviscosity risk, heart failure, previous immunoglobulin reaction and product-specific warnings. Record the actual product and batch. Slow or interrupt infusion for significant reaction and investigate headache, meningism, haemolysis, thrombosis or acute kidney injury. Avoid sucrose-containing formulations in people at renal risk where alternatives exist. Pregnancy does not itself preclude IVIG, but obstetric and neurology teams should jointly assess maternal thrombosis, volume and fetal considerations.
Plasma exchange requires reliable vascular access, trained staff and monitoring for hypotension, arrhythmia, citrate-related hypocalcaemia, bleeding and catheter infection. Autonomic instability may make exchanges difficult, while recent IVIG can be removed by subsequent exchange. Albumin or other replacement choice follows the apheresis service. Neither treatment should be delayed for lumbar puncture or nerve-conduction studies when a severely progressive clinical syndrome warrants immunotherapy. Conversely, the cost and scarcity of IVIG are not reasons to give an unverified course to a poorly fitting mimic.
Pain may be neuropathic, musculoskeletal or procedure-related. Use regular assessment and individualised analgesia; gabapentinoids, carbamazepine or other agents may cause sedation and complicate respiratory assessment, while opioids can suppress ventilation. Treat dysautonomia conservatively with short-acting, titratable drugs because hypertension can alternate with hypotension and bradycardia. Avoid unnecessary anticholinergic and sedating medicines. Renal impairment, obesity and paediatric weight require pharmacy input. Do not use oral or intravenous corticosteroids as disease-modifying treatment, and do not prescribe antibiotics for the antecedent infection unless an active infection still requires them.
When to Refer
Current guidelines advises immediate neurological assessment, including bulbar and respiratory evaluation, for rapidly progressive symmetrical limb weakness developing within four weeks. In practical terms, suspected GBS is not a routine outpatient referral. Arrange emergency transfer from a clinic or smaller hospital, give the receiving team onset and progression, walking ability, cranial and bulbar findings, cough, respiratory measurements, reflexes, autonomic observations and relevant exposures, and state whether the patient is deteriorating during transfer. Maintain airway readiness and do not send an unstable patient without appropriately skilled escort and monitoring.
Discuss ICU or high-dependency care before overt respiratory failure when there is rapidly declining vital capacity, inability to lift the head, weak cough, bulbar dysfunction, secretion retention, bilateral facial weakness, severe limb weakness or dysautonomia. Children require paediatric neurology and paediatric critical-care pathways. Pregnancy warrants combined neurology, obstetric, anaesthetic and neonatal planning. Suspected toxic, infectious or acute-flaccid-paralysis causes may need poison-centre, infectious-disease and public-health notification in parallel; referral should not erase those duties.
After the acute phase, refer early to physiotherapy, occupational therapy, speech and language therapy, dietetics, respiratory care, psychology and rehabilitation medicine according to deficits. Persistent foot drop, hand weakness, dysphagia, neuropathic pain, fatigue, anxiety or work and driving problems need follow-up rather than a binary recovered/not-recovered label. Recurrent or continuing deterioration must return to neurology to distinguish treatment-related fluctuation, acute-onset CIDP, complication or wrong diagnosis. In resource-limited Indian settings, name the destination, transport plan, funding route and follow-up owner; a referral letter alone is not a completed pathway.
Red Flags
Breathlessness at rest is a late and unreliable marker. Immediate critical-care review is required for a falling forced vital capacity, weak or inaudible cough, inability to clear secretions, pooling saliva, choking, nasal or slurred speech, paradoxical abdominal breathing, orthopnoea, rapid shallow breathing, exhaustion, altered consciousness or rising carbon dioxide. Normal pulse oximetry does not remove danger. Avoid feeding by mouth until swallowing safety is established when bulbar weakness is present. Plan airway intervention before severe hypoxaemia or an arrest.
Autonomic red flags include marked blood-pressure variability, sustained or profound tachycardia, bradycardia, pauses, arrhythmia, syncope, ileus and urinary retention. Continuous rhythm and frequent blood-pressure monitoring are appropriate in severe disease. Handle suctioning, line placement and mobilisation carefully because vagal stimulation can trigger bradyarrhythmia. Chest pain, unilateral swelling or sudden hypoxia raises venous thromboembolism, while fever, new infiltrates or purulent secretions raises aspiration or hospital-acquired infection.
Diagnostic red flags include a sensory level, extensor plantar responses, early severe bladder or bowel dysfunction, persistent fever at weakness onset, altered sensorium, fixed pupils, pronounced asymmetry, hyperreflexia with a central pattern, severe electrolyte abnormality or toxin exposure. More than 50 cells per microlitre in cerebrospinal fluid is strongly atypical, and even mild pleocytosis needs explanation. No improvement is not itself proof of an alternative, but continued progression beyond four weeks, deterioration beyond eight weeks or repeated treatment-related fluctuations requires specialist reclassification. Sudden focal weakness is a stroke or cord emergency until assessed, not an unusual form of routine GBS.
Indian Clinical Context
Indian pathways range from primary facilities without spirometry to tertiary neurological ICUs offering electrophysiology, IVIG and plasma exchange. At first contact, the high-value actions are recognising rapidly progressive weakness, documenting reflexes and bulbar function, measuring respiratory performance if equipment and cooperation permit, and transferring early. A normal chest radiograph or saturation cannot substitute for ventilation assessment. District services should establish links for ICU beds and apheresis before deterioration; long inter-hospital journeys require airway planning, monitoring and an escort capable of responding to respiratory or autonomic collapse.
IVIG may be faster to organise but is costly and intermittently scarce. Plasma exchange may lower acquisition cost yet requires apheresis expertise, vascular access, replacement fluid and haemodynamic tolerance. The options are clinically comparable in appropriately selected severe GBS, so local availability, contraindications and delay matter. Financial counselling must be honest: do not promise a superior outcome from a more expensive product or ask families to purchase repeat IVIG without an evidence-based indication. Public schemes, hospital social work and state referral networks should be engaged early.
India's infectious and toxic differentials deserve disciplined attention. Recent diarrhoea supports but does not prove GBS; neurotoxic envenomation, organophosphate exposure, diphtheria, hypokalaemic paralysis and acute flaccid myelitis may be locally salient. Acute flaccid paralysis surveillance obligations should be checked, especially in children. Rehabilitation access is uneven and often ends after discharge, although recovery can take months. A written plan should address pressure care, safe transfers, nutrition, pain, orthoses, home exercises, return to school or work and warning signs. Imported guidelines inform care but do not erase Indian formulary, ICU-capacity and public-health realities.
NMC Competency Mapping
This guide supports competency-based learning across physiology, medicine, paediatrics, anaesthesiology and emergency care rather than claiming one disease-specific undergraduate code. NMC physiology competency PY3.2 covers properties and types of peripheral nerve fibres, and PY3.3 addresses nerve injury, degeneration and regeneration; these provide the mechanistic basis for conduction failure, axonal loss and recovery. PY3.5 on neuromuscular-junction disorders is useful for distinguishing GBS from myasthenia and neuromuscular-blocking effects. Learners should connect these mechanisms to bedside localisation rather than memorise electrophysiological labels in isolation.
Clinical outcomes include taking a time-anchored weakness and infection history, examining tone, power and reflexes, localising peripheral versus central weakness, assessing cranial and bulbar function, and recognising ventilatory failure before oxygen desaturation. Interpretation skills include cerebrospinal-fluid protein and cell count, nerve-conduction patterns, electrolytes and spinal or brain imaging used to exclude mimics. Management competence means immediate referral, serial respiratory and autonomic surveillance, safe aspiration and thrombosis prevention, knowledge of IVIG and plasma-exchange indications, and understanding why corticosteroids are not effective.
Assessment should use evolving cases. A student may first identify symmetrical areflexic weakness, then respond to a falling vital capacity, and finally choose between supportive tests and time-critical treatment. Examiners should reward explicit escalation, airway and swallowing protection, differential diagnosis and acknowledgement that normal early cerebrospinal fluid or nerve conduction does not exclude GBS. Drug questions should test contraindication and monitoring rather than unsupported brand selection. At undergraduate level, learners explain and assist under supervision; they do not independently initiate IVIG, apheresis or intubation. The NMC curriculum sets educational outcomes, not a national therapeutic protocol.
Key Exam Pearls for NEET PG
GBS classically causes rapidly progressive, relatively symmetrical flaccid weakness with reduced reflexes; sensory symptoms and pain may occur, but objective sensory loss is often less prominent than motor weakness. Albuminocytological dissociation means raised cerebrospinal-fluid protein with a low cell count. It can be absent during the first week, so a normal early lumbar puncture is not an exclusion test. Marked pleocytosis should redirect the differential. Early nerve-conduction studies may also be normal or equivocal and can require repetition.
Know the variants without forcing every patient into one pattern. Acute inflammatory demyelinating polyradiculoneuropathy shows demyelinating features; AMAN and AMSAN are axonal. Miller Fisher syndrome is characterised by ophthalmoplegia, ataxia and areflexia and is associated with anti-GQ1b antibodies. Facial diplegia, pharyngeal-cervical-brachial weakness and paraparetic presentations occur. Preserved reflexes can occur in selected axonal or regional variants. A sensory level, extensor plantars and early severe sphincter dysfunction favour spinal or central disease.
The lifesaving answer is often monitoring, not a confirmatory test. Serial forced vital capacity, inspiratory strength where available, cough, swallowing, ECG and blood pressure detect respiratory, bulbar and autonomic deterioration. Pulse oximetry alone is inadequate. IVIG and plasma exchange shorten disability in appropriately selected patients; routinely combining them adds no proven benefit. Corticosteroids are ineffective. Do not wait for LP or NCS before treating rapidly progressive severe disease. After acute stabilisation, prevention of thrombosis, aspiration, pressure injury and contracture plus multidisciplinary rehabilitation is part of treatment, not an optional afterthought. Prognosis is generally favourable, but ventilation, axonal injury, fatigue, pain and residual weakness shape recovery.
Frequently Asked Questions
Can normal cerebrospinal fluid in the first week exclude Guillain-Barré syndrome?
No. Cerebrospinal-fluid protein may remain normal early, while the expected albuminocytological dissociation often becomes clearer later. Diagnosis rests on the clinical pattern, serial examination and exclusion of dangerous mimics. A substantial white-cell count is atypical and should trigger investigation for infectious, inflammatory or malignant alternatives. Lumbar puncture should not delay respiratory monitoring or indicated immunotherapy.
Are intravenous immunoglobulin and plasma exchange given together for faster recovery?
Not routinely. Either IVIG or plasma exchange is selected according to timing, severity, contraindications, access and local expertise. Sequential plasma exchange can remove infused immunoglobulin, and routine combination has not shown additional benefit. A second IVIG course given only because a prognostic score is poor is also not recommended. Unexpected worsening requires reassessment rather than automatic repetition.
Why can a patient with normal oxygen saturation still need intensive-care review?
Oxygen saturation measures oxygenation, not respiratory muscle reserve or carbon-dioxide clearance. A patient can retain carbon dioxide, lose cough strength and fail to protect the airway before saturation falls. Serial vital capacity, inspiratory effort, bulbar function, secretion handling and clinical trajectory are therefore essential. Planned escalation is safer than waiting for cyanosis, exhaustion or emergency intubation.
Do corticosteroids help Guillain-Barré syndrome, and how long does recovery take?
Corticosteroids do not improve GBS and should not be used as disease-modifying therapy. Recovery varies from weeks to many months and may continue after discharge. Some people retain fatigue, pain, foot drop or other weakness despite immunotherapy. Rehabilitation, pressure and thrombosis prevention, nutrition, communication support and follow-up for late deterioration are essential components of care.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic